The latest issue of Pharma Technology Focus is out now. Read it for free on all devices.

Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. Global trends indicate that initially, a slow supply did not allow African countries, in particular, to stay on pace to meet this target, and now vaccination rates have even begun to slow down. Given the deadline, we explore the current relevance and achievability of the WHO’s target, and why it proved challenging for some developing nations in Africa.  

Also in this issue, we take a look at efforts to tackle the opioid epidemic and how small biotechs and research labs appear to be at the forefront of innovative research in that domain.  

Don’t miss the data-led investigations into the demand for jobs in cybersecurity and big data in the pharmaceutical industry, and how artificial intelligence-led efforts in drug discovery may still only be at the start of a long development journey.  

Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a new issue is available.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.